142 results
6-K
EX-99.1
BLU
Bellus Health Inc
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
strategies, both in the short, and the long term, that will allow the Company to advance its development of products that provide innovative health … -term strategic and business objectives; and motivate and attract executives, and long-term equity incentives (granting of stock options) to encourage
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
than April 17, 2023. The Transaction Committee also discussed the Company’s long-term plan and prospects on a stand-alone basis, including the risks … achievement of the Company’s long-term plans;
the conditions to the Parent’s and the Purchaser’s obligation to complete the Arrangement and the right
6-K
EX-99.2
BLU
Bellus Health Inc
27 Apr 23
Material Change Report
6:04am
, long-term supply agreement or other arrangement having the same economic effect as a sale) of assets (including securities of Company Subsidiaries
6-K
EX-99.2
BLU
Bellus Health Inc
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
for implementing key strategies, both in the short, and the long term, that will allow the Company to advance its development of products that provide … the achievement of our key short-term strategic and business objectives; and motivate and attract executives, and long-term equity incentives (granting of stock
6-K
EX-99.1
BLU
Bellus Health Inc
29 Mar 23
Current report (foreign)
5:26pm
operations, develop camlipixant and prepare for commercialization.
We do not have any long-term debt and we do not have any pre-arranged credit … has initiated patient screening. However, the long-term clinical safety and effectiveness of camlipixant have to be demonstrated through further non
SUPPL
q4dwyu8s1x5mgv nz
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
EX-99.1
w9292d3 labukdqttos1
14 Nov 22
Open Market Sale Agreementsm
5:19pm
F-10
90nbr9 8t
26 Aug 22
Registration of securities (Canada)
4:48pm
SUPPL
ldye7jprio qu13yl
15 Jul 22
Supplemental materials (foreign)
7:01am
6-K
EX-99.2
t2pjc76j2
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
SUPPL
cvrr8l9d
13 Jul 22
Supplemental materials (foreign)
5:01pm
6-K
EX-99.2
1ey m6zzma25y
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
6-K
EX-99.2
1i8nen
7 Apr 22
Notice of Annual Meeting of Shareholders
9:01am
6-K
EX-99.1
2ijv02po53
5 Apr 22
Current report (foreign)
4:07pm
40-F
EX-99.3
y5m hloiebdq
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.1
qsvejjy77eahe vn
23 Feb 22
Annual report (Canada)
5:20pm
40-F
kcc8eiftr37sy0kifpqg
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.2
b997ro
15 Dec 21
BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States
5:15pm
SUPPL
q3udx
15 Dec 21
Supplemental materials (foreign)
5:10pm
F-10
32e5n4kbq
14 Dec 21
Registration of securities (Canada)
9:43am